
伊格列净减轻2型糖尿病患者体质量有效性与安全性系统评价*
Efficacy and Safety of Ipragliflozin in Reducing Body Mass in Patients with Type 2 Diabetes Mellitus:A Systematic Review
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |